Zobrazeno 1 - 10
of 85
pro vyhledávání: '"A.-M. Udén"'
Publikováno v:
Natural Hazards and Earth System Sciences, Vol 14, Iss 2, Pp 443-457 (2014)
The paper presents an experiment demonstrating a novel and successful application of delay- and disruption-tolerant networking (DTN) technology for automatic data transfer in a karst cave early warning and measuring system. The experiment took place
Externí odkaz:
https://doaj.org/article/b8c083588f1d4aea814f78e6240934b6
Publikováno v:
Natural Hazards and Earth System Sciences, Vol 14, Iss 2, Pp 443-457 (2014)
The paper presents an experiment demonstrating a novel and successful application of delay- and disruption-tolerant networking (DTN) technology for automatic data transfer in a karst cave early warning and measuring system. The experiment took place
Autor:
Bo Nilsson, Håkan Mellstedt, Bengt Smedmyr, H. Gyllenhammar, Bertil Johansson, Richard A. Lerner, Anders Österborg, C. Paul, Gunnar Juliusson, H. Strander, C. Wedelin, Eva Kimby, B. Wadman, G. Brenning, A.-M. Stalfelt, Anders Ahre, G. Gahrton, Andreas Killander, Erik Svedmyr, Magnus Björkholm, Bengt Simonsson, M. Björeman, M. Järnmark, A.-M. Udén
Publikováno v:
European Journal of Haematology. 43:54-62
86 previously untreated patients with multiple myeloma stage III entered a randomized trial comparing combination chemotherapy (VMCP/VBAP) (n = 42) with intermittent oral melphalan and prednisone (MP) treatment (n = 44). The treatment gropus were wel
Autor:
Håkan Mellstedt, Gunnar Juliusson, Eva Ösby, Bengt Simonsson, Bengt Smedmyr, C. Paul, B. Wadman, Bertil Johansson, Erik Svedmyr, H. Strander, Magnus Björkholm, M. Björeman, H. Gyllenhammar, Andreas Killander, Karl Merk, G. Brenning, G. Grimfors, G. Gahrton, A.-M. Stalfelt, Eva Kimby, Richard A. Lerner, M. Järnmark, A.-M. Udén, Anders Österborg, R. Hast
Publikováno v:
European Journal of Haematology. 43:124-128
A randomized study comparing melphalan/prednisone (M/P) therapy with MP + natural alpha-IFN in untreated patients with multiple myeloma stages II and III started April 1, 1986. By March 1989, 78 patients were evaluable in the MP group and 80 in the M
Autor:
Gunnar Öberg, G. Gahrton, Richard A. Lerner, Astrid Gruber, C. Paul, A.-M. Stalfelt, Ulf Tidefelt, Magnus Björkholm, G. Grimfors, Bengt Simonsson, S. Mattson, A.-M. Udén, Robert Hast, Leif Stenke, Jan Liliemark, M. Björeman, Andreas Killander
Publikováno v:
European Journal of Haematology. 68:376-381
It is still controversial how to treat elderly patients with acute myeloid leukaemia (AML), and results have been poor with most regimens. We report the long-term results of a randomised study performed by the Leukaemia Group of Middle Sweden during
Autor:
R. Lerner, A. Killander, Håkan Mellstedt, Åke Öst, A.-M. Stalfelt, B. Simonsson, B. Wadman, Eva Kimby, E. Svedmyr, K.-H. Robért, B. Johansson, Magnus Björkholm, Eva Löfvenberg, Bengt Glimelius, Anders Wahlin, Christer Sundström, Gunnar Juliusson, Hans Hagberg, M. Järnmark, Gösta Gahrton, A.-M. Udén, C. Lindemalm, H. Johansson, U. Pettersson
Publikováno v:
Annals of Oncology. 5:S67-S71
Two hundred fifty-nine previously untreated patients with low-grade non-Hodgkin's lymphomas (NHLs), Ann Arbor stages III and IV, entered a randomized multicenter trial comparing the therapeutic effect of chlorambucil/prednisone (ChP) vs. CHOP. All pa
Autor:
L. H. Eklund, Gunnar Grimfors, A.-M. Udén, N. Kållberg, Magnus Björkholm, S. Eksborg, O. T. Juneskans
Publikováno v:
Journal of Internal Medicine. 230:173-177
The case of a granulocytopenic patient with acute undifferentiated leukaemia and hepatosplenic candidiasis who was refractory to conventional deoxycholate amphotericin B (AmpB) and 5-flucytosine therapy is reported. He experienced severe AmpB-related
Autor:
G, Oberg, A, Killander, M, Björeman, G, Gahrton, G, Grimfors, A, Gruber, R, Hast, R, Lerner, J, Liliemark, S, Mattson, C, Paul, B, Simonsson, A-M, Stalfelt, L, Stenke, U, Tidefelt, A-M, Udén, M, Björkholm
Publikováno v:
European journal of haematology. 68(6)
It is still controversial how to treat elderly patients with acute myeloid leukaemia (AML), and results have been poor with most regimens. We report the long-term results of a randomised study performed by the Leukaemia Group of Middle Sweden during
Publikováno v:
Cardiology. 94(3)
Reduced heart rate variability (HRV) after acute myocardial infarction (AMI) indicates poor prognosis. HRV in patients with uncomplicated coronary artery disease is reduced, and an association with poor prognosis has been suggested. The mechanism of
Autor:
B, Simonsson, G, Oberg, A, Killander, M, Björeman, M, Björkholm, G, Gahrton, L, Stenke, I, Turesson, A M, Udén, C, Malm
Publikováno v:
Bone marrow transplantation. 14